Antipodes Partners’s Establishment Labs ESTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$82.7K Buy
+964
New +$69.3K ﹤0.01% 107
2026
Q1
Sell
-969
Closed -$70.6K 134
2025
Q4
$70.6K Sell
969
-338
-26% -$20.4K ﹤0.01% 97
2025
Q3
$53.6K Sell
1,307
-741
-36% -$30.3K ﹤0.01% 93
2025
Q2
$87.5K Buy
2,048
+73
+4% +$2.55K ﹤0.01% 77
2025
Q1
$80.6K Buy
+1,975
New +$73.6K ﹤0.01% 77

Other funds holding ESTA

Antipodes Partners's ESTA Position: Q2 2026 in Review

Antipodes Partners opened a new position in Establishment Labs (ESTA) in Q2 2026: 964 shares worth $82.7K. The stake represents ﹤0.01% of the portfolio and ranks #107 among its holdings. This is a return to the name: Antipodes Partners previously reported a position in ESTA as recently as Q4 2025.

Antipodes Partners first reported a position in ESTA in Q1 2025 and has held it in 5 quarters since. The position peaked at $87.5K in Q2 2025. 196 funds tracked by Wall St. Rank hold ESTA as of Q2 2026.

  • Antipodes Partners held 964 shares of Establishment Labs worth $82.7K as of Q2 2026.
  • Establishment Labs was a new Antipodes Partners position in Q2 2026.
  • Establishment Labs made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #107 holding.
  • Antipodes Partners first reported a position in Establishment Labs in Q1 2025 and has held it in 5 quarters since.
  • Antipodes Partners's Establishment Labs position peaked at $87.5K in Q2 2025.
  • 196 funds tracked by Wall St. Rank held Establishment Labs as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.